retatrutide release date FDA Approval Status: July 2026 Update Lilly's retatrutide press release June

One study found the cost of weight loss per kilogram associated with orlistat was US$546, with a cost of US$71,000 per quality-adjusted life year (QALY) in Europe [13]

91% achieved 15% reduction at highest dose

Phentermine-topiramate (Qsymia) Topiramate, long used for seizure disorders and chronic migraine headache, was approved for obesity treatment in an extended-release combination with phentermine in 2012

Safety is unknown

doi: 10.1210/endocr/bqae155 24 HalimMADegerbladMSundbomMKarlbomUHolstJJWebbDLet al

Either way, considering the cost of these medications and the prevalence of both diabetes or obesity within a population, there is a potential for significant costs for the payers employers, employees or health insurance companies